HK1231495A1 - 用於製備催產素類似物的方法 - Google Patents
用於製備催產素類似物的方法Info
- Publication number
- HK1231495A1 HK1231495A1 HK17105259.6A HK17105259A HK1231495A1 HK 1231495 A1 HK1231495 A1 HK 1231495A1 HK 17105259 A HK17105259 A HK 17105259A HK 1231495 A1 HK1231495 A1 HK 1231495A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- processes
- preparation
- oxytocin analogues
- oxytocin
- analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP14180161 | 2014-08-07 | ||
PCT/EP2015/067881 WO2016020349A1 (en) | 2014-08-07 | 2015-08-04 | Processes for the preparation of oxytocin analogues |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1231495A1 true HK1231495A1 (zh) | 2017-12-22 |
Family
ID=51298582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK17105259.6A HK1231495A1 (zh) | 2014-08-07 | 2017-05-24 | 用於製備催產素類似物的方法 |
Country Status (19)
Country | Link |
---|---|
US (1) | US20170174725A1 (zh) |
EP (1) | EP3177635B1 (zh) |
JP (1) | JP6744293B2 (zh) |
KR (1) | KR20170040231A (zh) |
CN (1) | CN106573958A (zh) |
AU (1) | AU2015299118B2 (zh) |
CA (1) | CA2954228A1 (zh) |
ES (1) | ES2700586T3 (zh) |
HK (1) | HK1231495A1 (zh) |
HR (1) | HRP20181916T1 (zh) |
IL (1) | IL248981B (zh) |
MX (1) | MX369345B (zh) |
MY (1) | MY178266A (zh) |
PL (1) | PL3177635T3 (zh) |
RU (1) | RU2696276C2 (zh) |
SG (1) | SG11201700877PA (zh) |
SI (1) | SI3177635T1 (zh) |
TR (1) | TR201815872T4 (zh) |
WO (1) | WO2016020349A1 (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201506885UA (en) | 2013-03-21 | 2015-09-29 | Sanofi Aventis Deutschland | Synthesis of cyclic imide containing peptide products |
AU2014234400B2 (en) | 2013-03-21 | 2017-11-16 | Sanofi-Aventis Deutschland Gmbh | Synthesis of hydantoin containing peptide products |
CN112773765A (zh) | 2014-09-19 | 2021-05-11 | 辉凌公司 | 治疗普拉德-威利综合征的方法 |
CN112969450B (zh) | 2018-09-20 | 2023-05-30 | 阿卡蒂亚药品公司 | 卡贝缩宫素药物产品及用于制备其的方法 |
CN112839632A (zh) | 2018-09-20 | 2021-05-25 | 莱沃疗法公司 | 稳定的鼻内卡贝缩宫素制剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2063979C1 (ru) * | 1992-02-24 | 1996-07-20 | Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов | Пептиды последовательности окситоцина |
CA2149783A1 (en) * | 1993-09-21 | 1995-03-30 | Kenji Shibata | Novel peptides |
FI20021763A0 (fi) * | 2002-10-03 | 2002-10-03 | Karyon Oy Ab Ltd | Uusia terapeuttisesti aktiivisia aineita ja niiden käyttö |
JP4564375B2 (ja) * | 2004-08-18 | 2010-10-20 | 太陽化学株式会社 | テアニンの製造方法 |
RS57690B1 (sr) * | 2012-12-21 | 2018-11-30 | Hoffmann La Roche | Peptidi kao agonisti oksitocina |
-
2015
- 2015-08-04 CN CN201580035667.8A patent/CN106573958A/zh active Pending
- 2015-08-04 KR KR1020177003094A patent/KR20170040231A/ko not_active Application Discontinuation
- 2015-08-04 MY MYPI2016002054A patent/MY178266A/en unknown
- 2015-08-04 SI SI201530502T patent/SI3177635T1/sl unknown
- 2015-08-04 RU RU2017105184A patent/RU2696276C2/ru active
- 2015-08-04 JP JP2017506865A patent/JP6744293B2/ja not_active Expired - Fee Related
- 2015-08-04 MX MX2016016050A patent/MX369345B/es active IP Right Grant
- 2015-08-04 TR TR2018/15872T patent/TR201815872T4/tr unknown
- 2015-08-04 AU AU2015299118A patent/AU2015299118B2/en not_active Ceased
- 2015-08-04 ES ES15745209T patent/ES2700586T3/es active Active
- 2015-08-04 WO PCT/EP2015/067881 patent/WO2016020349A1/en active Application Filing
- 2015-08-04 PL PL15745209T patent/PL3177635T3/pl unknown
- 2015-08-04 SG SG11201700877PA patent/SG11201700877PA/en unknown
- 2015-08-04 CA CA2954228A patent/CA2954228A1/en not_active Abandoned
- 2015-08-04 EP EP15745209.5A patent/EP3177635B1/en active Active
-
2016
- 2016-11-15 IL IL248981A patent/IL248981B/en active IP Right Grant
-
2017
- 2017-02-07 US US15/426,550 patent/US20170174725A1/en not_active Abandoned
- 2017-05-24 HK HK17105259.6A patent/HK1231495A1/zh unknown
-
2018
- 2018-11-16 HR HRP20181916TT patent/HRP20181916T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
IL248981B (en) | 2021-02-28 |
CA2954228A1 (en) | 2016-02-11 |
WO2016020349A1 (en) | 2016-02-11 |
MX369345B (es) | 2019-11-06 |
RU2017105184A (ru) | 2018-09-07 |
SI3177635T1 (sl) | 2019-01-31 |
MY178266A (en) | 2020-10-07 |
EP3177635A1 (en) | 2017-06-14 |
US20170174725A1 (en) | 2017-06-22 |
RU2696276C2 (ru) | 2019-08-01 |
EP3177635B1 (en) | 2018-10-03 |
ES2700586T3 (es) | 2019-02-18 |
JP2017527545A (ja) | 2017-09-21 |
MX2016016050A (es) | 2017-02-28 |
AU2015299118B2 (en) | 2020-07-09 |
HRP20181916T1 (hr) | 2019-01-11 |
PL3177635T3 (pl) | 2019-02-28 |
IL248981A0 (en) | 2017-01-31 |
SG11201700877PA (en) | 2017-03-30 |
JP6744293B2 (ja) | 2020-08-19 |
KR20170040231A (ko) | 2017-04-12 |
RU2017105184A3 (zh) | 2019-02-15 |
AU2015299118A1 (en) | 2016-12-01 |
TR201815872T4 (tr) | 2018-11-21 |
CN106573958A (zh) | 2017-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL250089A0 (en) | Metrology of multiple sampling processes | |
IL281292B1 (en) | Processes for preparing a diarylthiohydantoin compound | |
IL250441A0 (en) | A method for the production of 5-fluoro-1h-pyrazoles starting from hexafluoropropane | |
HRP20181916T1 (hr) | Postupci pripreme oksitocinskih analoga | |
IL248267B (en) | A process for preparing converted cycloserines | |
IL248566B (en) | A process for the preparation of 5-fluoro-1h-pyrazoles from hexafluoropropane | |
PL3189072T3 (pl) | Analogi peptydowe gip | |
ZA201607059B (en) | Omega-3 analogues | |
IL257803B (en) | Peptide analogs derived from vdac1 | |
ZA201701973B (en) | Process for the preparation of halo-substituted trifluoroacetophenones | |
IL247443B (en) | Process for the preparation of 5-fluorotryptophol | |
IL249130A0 (en) | Preparation of piperidine-4-carbthioamide | |
HUP1400518A2 (hu) | Eljárás tofacitinib elõállítására | |
GB201407532D0 (en) | Apelin analogues | |
GB201410103D0 (en) | Tunicamycin analogues | |
GB201407565D0 (en) | Apelin analogues |